1. Home
  2. BLCO vs SNEX Comparison

BLCO vs SNEX Comparison

Compare BLCO & SNEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bausch + Lomb Corporation

BLCO

Bausch + Lomb Corporation

HOLD

Current Price

$16.41

Market Cap

6.0B

Sector

Health Care

ML Signal

HOLD

Logo StoneX Group Inc.

SNEX

StoneX Group Inc.

HOLD

Current Price

$105.62

Market Cap

4.9B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
BLCO
SNEX
Founded
1853
1924
Country
Canada
United States
Employees
N/A
5400
Industry
Ophthalmic Goods
Investment Bankers/Brokers/Service
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
6.0B
4.9B
IPO Year
2022
1996

Fundamental Metrics

Financial Performance
Metric
BLCO
SNEX
Price
$16.41
$105.62
Analyst Decision
Buy
Strong Buy
Analyst Count
12
2
Target Price
$18.55
$122.00
AVG Volume (30 Days)
452.1K
319.9K
Earning Date
01-01-0001
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
2.50
Revenue
$5,101,000,000.00
$132,378,200,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$5.52
$3.69
P/E Ratio
N/A
$42.10
Revenue Growth
6.47
32.53
52 Week Low
$10.45
$65.58
52 Week High
$18.92
$132.57

Technical Indicators

Market Signals
Indicator
BLCO
SNEX
Relative Strength Index (RSI) 37.97 37.32
Support Level $16.35 $92.71
Resistance Level $16.81 $131.46
Average True Range (ATR) 0.51 4.84
MACD -0.22 -2.83
Stochastic Oscillator 9.80 13.77

Price Performance

Historical Comparison
BLCO
SNEX

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

About SNEX StoneX Group Inc.

StoneX Group Inc is a Global brokerage and financial services firm. Its service offerings are execution, OTC / Market-Making, advisory services, Global payment solutions, market intelligence, Physical Trading and clearing services. The firm operates in four segments: Commercial, Institutional, Self-Directed/Retail, and Payments. Its customers include governmental and nongovernmental organizations, commercial banks, brokers, institutional investors, and investment banks. The company operates in the United States, South America, Europe, the Middle East and Asia, and other countries, out of which the majority of revenue is generated from the Middle East and Asia Region.

Share on Social Networks: